Executive
Management Team.
Dr. Roger S. McIntyre
Chairman and Chief Executive Officer
Dr. Roger McIntyre is the chairman and chief executive officer of Braxia Scientific. Dr. McIntyre is the world’s top-ranked depression researcher and has almost 25 years of providing care and conducting research, along with drug discovery and development, for persons with depression and related disorders. He is currently also a professor of psychiatry and pharmacology at the University of Toronto and Head of the Mood Disorders Psychopharmacology Unit at the University Health Network in Toronto, Canada.
Peter Rizakos
Chief Legal Officer
Peter Rizakos is the chief legal officer of Braxia Scientific. Mr. Rizakos has 30 years of experience as a corporate and securities lawyer, and as an executive in a variety of roles in both established and early-stage businesses. Mr. Rizakos has extensive experience with both public and private companies, including implementing growth strategies, capital-raising and asset acquisition, legal and regulatory compliance and board and governance matters. Mr. Rizakos is a member of the Law Society of Ontario, has an MBA from INSEAD and an LLB from Osgoode Hall Law School.
Josh Rosenblat
Chief Medical and Scientific Officer
Dr. Joshua Rosenblat is the chief scientific and medical officer of Braxia Scientific. Dr. Rosenblat also oversees clinical care and several research projects at the Canadian Rapid Treatment Center of Excellence, a wholly owned subsidiary of Braxia Scientific. He has personally treated hundreds of patients with ketamine and has extensive direct clinical and research experience in this area.
Kevin Kratiuk
Vice President, Operations, Braxia Health Clinics
Kevin Kratiuk has been the Vice-President of Operations since July 2018. He obtained his Doctor of Pharmacy degree from Poznan University of Medical Sciences in 2014. Alongside CRTCE, Kevin also founded KJK Health, which consists of a family practice clinic alongside KJK Pharmacy. In addition, he has been providing medical education consults since 2010 to over 1,000 Canadian medical students studying abroad.
Jason Wolkove
Chief Information Officer, Braxia Scientific
Braxia’s new Chief Information Officer, Jason Wolkove, is a seasoned technology executive bringing more than 20 years of experience growing complex technical product, sales and service teams and building SaaS software systems. Jason also brings deep expertise in both revenue cycle, data management and mining, and a proven ability to manage product development.
Dr. Roger S. McIntyre
Chairman and Chief Executive Officer
Peter Rizakos
Chief Legal Officer
Josh Rosenblat
Chief Medical & Scientific Officer
Kevin Kratiuk
Vice President, Operations, Braxia Health Clinics
Jason Wolkove
Chief Information Officer, Braxia Scientific